-
Sector Analysis
Engineered Exosomes - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
Engineered exosomes are small vesicles secreted by cells that have been modified to carry specific cargo, such as drugs or therapeutic molecules. These engineered exosomes have shown great potential as delivery vehicles for targeted therapy in various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. By loading exosomes with therapeutic agents and targeting them to specific cells or tissues, researchers aim to improve the efficacy and reduce the side effects of traditional drug delivery methods. This emerging field of research...
-
Product Insights
Myelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Myelodysplastic Syndrome - Global Clinical Trials Review, 2025" provides an overview of Myelodysplastic Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Myelodysplastic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Bile Duct Cancer (Cholangiocarcinoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
B-cell Depletion - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
B-Cell Depletion Report Overview B cell depletion is a therapeutic strategy to reduce the number of B lymphocytes, which play a crucial role in autoimmune diseases and certain cancers. The approach primarily treats conditions like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. Furthermore, the underlying patent publication growth shows an accelerating innovation trend within this field. Big pharma dominates the patent activity followed by private companies, startups, and small biotech. B-cell depletion is an accelerating innovation among 80+ innovation...
-
Product Insights
Relapsed Multiple Myeloma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Relapsed Multiple Myeloma Clinical Trial Report Overview A total of 1702 relapsed multiple myeloma clinical trials were conducted as of November 2024. The relapsed multiple myeloma clinical trial report offers a comprehensive understanding of disease clinical trials across regions, and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. Furthermore, the report includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      Asia-Pacific ·      ...
-
Product Insights
Refractory Multiple Myeloma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Refractory Multiple Myeloma Clinical Trial Report Overview A total of 1726 refractory multiple myeloma clinical trials were conducted as of November 2024. The refractory multiple myeloma clinical trial report offers a comprehensive understanding of disease clinical trials across regions, and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. Furthermore, the report includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      Asia-Pacific ·      ...
-
Product Insights
Burkitt Lymphoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Burkitt Lymphoma Clinical Trial Report Overview A total of 474 Burkitt lymphoma clinical trials were conducted as of November 2024. The Burkitt lymphoma clinical trial report provides a comprehensive understanding of the Burkitt lymphoma clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      Asia-Pacific ·      North...
-
Sector Analysis
Bladder Cancer Epidemiology Analysis and Forecast to 2033
Bladder Cancer Report Overview In the 8MM, there were 2,79,419 diagnosed incident cases of bladder cancer in 2023. The diagnosed incident cases of bladder cancer will register an AGR of more than 2% during 2023-2033. Bladder cancer is a type of cancer that begins in the urinary bladder, most often in the urothelial cells lining the inside of the urinary bladder. Globally, it is the ninth most common type of cancer. Diagnosis of the disease is both challenging and expensive since...
-
Product Insights
Colorectal Cancer Screening Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline Market Report Overview Colorectal cancer screening tests are carried out to monitor the bowel health of at-risk individuals, typically the elderly, to be able to detect and treat colorectal cancer in time. The Colorectal Cancer Screening Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the...
-
Sector Analysis
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Esophageal Cancer Marketed and Pipeline Drugs Report Overview Esophageal cancer (EC) is a malignant tumor in the esophagus’s inner layer (mucosa) and grows outside. The esophagus is a hollow, muscular tube that connects the throat to the stomach, facilitating the movement of food and aiding in digestion. EC is histologically classified as squamous cell carcinoma (SCC) and esophageal adenocarcinoma (EAC). The classification is based on the type of cell it starts in, which differs in its etiology, pathology, tumor location, therapeutics,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.